us-hospitals-to-restrict-lilly-covid-19-antibody-treatment-due-to-limited-supply
Spread the love

U.S. hospitals, weighing high demand and tight supplies, said they may limit use of a new Eli Lilly and Co antibody drug to COVID-19 patients with multiple risk factors for serious illness or to those whose immune systems have not begun to fight the infection. The treatment, bamlanivimab, was …